Yahoo · Oct 6, 2026
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
European equities traded in the US as American depositary receipts were tracking higher late Tuesday
TR
NASDAQ · TRIB
Trinity Biotech plc
Healthcare · Medical - Diagnostics & Research
$6.56
Down-$0.26 (-3.96%)
Updated Nov 4, 2026, 9:07 PM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 11.32M
- P/E ratio
- -0.54
- Dividend yield
- 0.00%
- 52-week range
- $0.31 – $14.17
- Volume
- 12.24K
- Avg. volume
- 97.99K
Price performance · TRIB
TRIB price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
TRIB closed at $6.56 after 21 trading sessions, down 8.25% for the selected period.
- Last close
- $6.56
- Period change
- -8.25%
- Period low
- $6.04
- Period high
- $8.19
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $6.795 | $6.795 | $6.315 | $6.56 | 12.24K |
| Nov 2, 2026 | $6.27 | $6.85 | $6.27 | $6.795 | 19.94K |
| Oct 30, 2026 | $6.4341 | $6.4341 | $6.26 | $6.26 | 6.7K |
| Oct 29, 2026 | $6.765 | $7.01 | $6.31 | $6.63 | 26.7K |
| Oct 28, 2026 | $7.2314 | $7.2314 | $6.69 | $6.80 | 11.01K |
| Oct 27, 2026 | $7.57 | $7.57 | $7.15 | $7.15 | 1.86K |
| Oct 26, 2026 | $7.30 | $7.50 | $7.1118 | $7.1118 | 14.68K |
| Oct 23, 2026 | $7.59 | $7.7977 | $7.265 | $7.2993 | 14.68K |
| Oct 22, 2026 | $7.75 | $7.9566 | $7.51 | $7.51 | 4.74K |
| Oct 21, 2026 | $7.65 | $7.89 | $7.46 | $7.75 | 10.71K |
| Oct 20, 2026 | $8.12 | $8.12 | $7.5684 | $7.79 | 3.95K |
| Oct 19, 2026 | $7.97 | $8.7599 | $7.62 | $8.19 | 9.13K |
| Oct 16, 2026 | $7.3705 | $8.7657 | $7.3705 | $8.03 | 28.66K |
| Oct 15, 2026 | $6.22 | $8.36 | $6.2101 | $7.93 | 27.38K |
| Oct 14, 2026 | $6.8223 | $7.2041 | $6.22 | $6.61 | 10.55K |
| Oct 13, 2026 | $7.05 | $7.51 | $6.30 | $6.30 | 18.73K |
| Oct 12, 2026 | $7.09 | $7.6916 | $6.5303 | $6.56 | 23.04K |
| Oct 9, 2026 | $6.42 | $7.2299 | $6.05 | $6.855 | 33.93K |
| Oct 8, 2026 | $6.70 | $6.80 | $5.83 | $6.04 | 13.06K |
| Oct 7, 2026 | $7.16 | $7.16 | $6.71 | $6.75 | 9.42K |
| Oct 6, 2026 | $6.09 | $7.34 | $5.97 | $7.15 | 41.64K |
Latest TRIB news
The latest Smart Investors Daily articles mentioning TRIB.
Stock researchCompany · Overview
Company
Market Activity
Research & News
TRIB research
Overview
Company profile and research snapshot.
Company profile
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $3.06
- Implied upside
- —
- Analysts
- 7
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 5, 2016 | Stephens & Co. | Equal-weight | — |
| Oct 5, 2016 | Stephens & Co. | Equal-weight | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 9, 2026
Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure
Trinovium to supply RTI with advanced fluids and analytical systems for deployment in a U.S. commercial pilot focused on AI and high-performance computing data center infrastructure Data center power densities are increasing rapidly as AI workloads expand, creating greater thermal-management demands and interest in advanced liquid cooling solutions DUBLIN and WILSONVILLE, Ore., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company, today
Benzinga · Sep 9, 2026
Trinity Biotech's Liquid Cooling Unit Trinovium Enters Contract With Red Team Investments, Owner Of Modular Data Center Technology X-MDC
The contract establishes a framework for Trinovium and RTI to develop and deploy direct-to-chip liquid cooling solutions for artificial intelligence ("AI"), high-performance computing ("HPC") and modular
Yahoo · Aug 28, 2026
Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
- Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress - PrePsia™ patent portfolio expands to nine granted U.S. and European patents - Company issues update on Nasdaq listing DUBLIN, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today provided an update on key developments across its diagnostics business, highlighting co
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
